Literature DB >> 15968839

The negative symptoms of schizophrenia: a cognitive perspective.

Neil A Rector1, Aaron T Beck, Neal Stolar.   

Abstract

Recent reports of improvement in the negative symptoms of schizophrenia following targeted cognitive interventions have prompted interest in the cognitive underpinnings of these symptoms. This review integrates current experimental research with the phenomenological accounts of patients participating in cognitive therapy for these specific symptoms. We propose that, in addition to the well-established role of neurobiological factors in their development and maintenance, specific cognitive appraisals and beliefs play a role in the expression and persistence of negative symptoms. This cognitive model of negative symptoms is based on a diathesis-stress formulation: a continuum of predispositional traits from the premorbid personality to the full-blown negative symptomatology, the incorporation of negative social and performance attitudes within these traits, and low expectancies for pleasure or success in goal-oriented activities. We suggest that negative symptoms represent, in part, a compensatory pattern of disengagement in response to threatening delusional beliefs, perceived social threat, and anticipated failure in tasks and social activities. A psychological aspect of this motivational and behavioural inertia appears to be the patient's perception of limited psychological resources--a perception that motivates patients to conserve energy by minimizing investment in activities requiring effort.

Entities:  

Mesh:

Year:  2005        PMID: 15968839     DOI: 10.1177/070674370505000503

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  51 in total

1.  The challenges of fitting an item response theory model to the Social Anhedonia Scale.

Authors:  Steven P Reise; William P Horan; Jack J Blanchard
Journal:  J Pers Assess       Date:  2011-05

2.  Beyond Depression: Towards a Process-Based Approach to Research, Diagnosis, and Treatment.

Authors:  Marie J C Forgeard; Emily A P Haigh; Aaron T Beck; Richard J Davidson; Fritz A Henn; Steven F Maier; Helen S Mayberg; Martin E P Seligman
Journal:  Clin Psychol (New York)       Date:  2011-12

3.  The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

Authors:  Eri Nakagami; Maanse Hoe; John S Brekke
Journal:  Schizophr Bull       Date:  2010-05-12       Impact factor: 9.306

4.  Defeatist beliefs as a mediator of cognitive impairment, negative symptoms, and functioning in schizophrenia.

Authors:  Paul M Grant; Aaron T Beck
Journal:  Schizophr Bull       Date:  2008-02-27       Impact factor: 9.306

5.  [New developments in psychotherapy for schizophrenic psychoses].

Authors:  S Klingberg; G Buchkremer
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

6.  Spared and impaired aspects of motivated cognitive control in schizophrenia.

Authors:  Claire L Mann; Owen Footer; Yu Sun Chung; Lori L Driscoll; Deanna M Barch
Journal:  J Abnorm Psychol       Date:  2013-07-08

Review 7.  Anhedonia in schizophrenia.

Authors:  Daniel H Wolf
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

8.  The relationship of attitudinal beliefs to negative symptoms, neurocognition, and daily functioning in recent-onset schizophrenia.

Authors:  Joseph Ventura; Kenneth L Subotnik; Arielle Ered; Denise Gretchen-Doorly; Gerhard S Hellemann; Anja Vaskinn; Keith H Nuechterlein
Journal:  Schizophr Bull       Date:  2014-02-21       Impact factor: 9.306

9.  Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia.

Authors:  William P Horan; Yuri Rassovsky; Robert S Kern; Junghee Lee; Jonathan K Wynn; Michael F Green
Journal:  J Psychiatr Res       Date:  2009-12-14       Impact factor: 4.791

Review 10.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.